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Abstract
There are mounting evidences showing the relation of chronic inflammatory 
and autoimmune diseases with the uncontrolled intensification of gut dysbiosis. 
This position asserts that an elevated presence of pathogens and bacterial, fungal, 
and viral components is directly involved in inflammatory metabolic diseases with 
a strong alteration of autoimmune components such as in inflammatory bowel 
syndrome (IBS), ulcerative colitis, and Crohn’s disease. Furthermore, the increase 
of unbalanced enteric microbiota is also connected to other types of conditions of 
metabolic origin such as diabetes mellitus, atherosclerosis, and osteo-degenerative 
conditions. As a matter of fact, evidence confirmed that gut damages histologically 
inspected revealed a situation with high expression of pro-inflammatory cytotumor 
necrosis factor-alpha (TNF-α), and IL1β, IL-2, IL-4, IL-6, and IL-17 together with 
high level of mucin-2. This chapter focuses on diverse topics related to microbiota 
dysfunction and systemic health condition and regenerative capacity and the 
therapeutic role of probiotics in gut health and disease emphasizing the potential 
beneficial role of probiotics in idiopathic inflammatory metabolic diseases. In brief, 
outcomes demonstrate that an intimate relationship between microbiota, metabo-
lism, tissue/cellular damages, and regeneration is standing. Within this scenario, 
the gut certainly plays a big part of the regenerative mechanisms in translational 
medicine.
Keywords: inflammatory bowel syndrome, ulcerative colitis, Crohn’s disease, gut 
dysbiosis, short-chain fatty acids, central nervous system, experimental autoimmune 
encephalopathy, vagus nerve, tumor necrosis factor-alpha, IL1β, IL-2, IL-4, IL-6, 
IL-17, mucin-2, probiotics
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1. Introduction
The oral-gastro-intestinal-sex-skin can be classified as unique large and 
heterogeneous apparatus populated by a huge variety of microorganisms, 
bacteria, virus, fungi, and other single-celled creatures, that compose the totality 
of human microbiota that contributes together with bone/skeleton system, to 
maintain the body energy homeostasis. The human body hosts something like 
10–100 trillion microbial cells that coexist in a strict fruitful symbiotic relation-
ship that persists as long as the body is kept in a balanced healthy state [1, 2]. 
The gut plays an important role in regulating metabolic immune activities. The 
gut’s essential task is the absorption of nutrients and the synthesis of important 
micromolecules obtained from food that cannot be assimilated by the stomach 
and small intestine [1–3]. Xyloglucans and fructo-oligosaccharides from veg-
etables and fruits, protein, and lipids; the assimilation of essential vitamins like 
vitamins B-12, D, and K; and the synthesis of hormones like serotonin from 
tryptophan amino acid take place right in the gut, thanks to the constant activity 
of its entire microbiota. The microbiota are able to produce 50–100 mmol·L—1 
per day of extremely important short-chain fatty acids (SCFAs), such as acetic, 
propionic, and butyric acids—and serve as an energy source to the host intestinal 
epithelium and skeleton [1–4].
The importance of SCFAs has been well described by several studies during the 
last decade; the activity of acetic acid, for instance, has been found to be essen-
tial against infections, in blood pressure regulation and against sclerotic plaque 
deposition in arterial walls. The presence of butyric acid is an essential anti-IBS 
agent due to its immune-modulator properties and anti-inflammatory action, 
while propionic acid has been found to be important in preventing obesity and 
diabetes 2 [1–4].
Although bacteria, viruses, and fungi might be very harmful and dangerous, 
they are indispensable for life as well. This symbiotic coexistence throughout the 
millennia made a deep crucial biological impact on human species, and it has 
become essential not only for survival but for evolution as well. Accumulating 
evidences have clearly demonstrated how part of these specific microorganisms 
can resume specific immunomodulatory roles and the way they affect either 
composition function or migration of various immune cell subpopulations from 
one site to a different location. For instance, oral macrophages may migrate 
under the influence of specific signal induction of local microbiota from oral 
either to the lungs or even the brain passing through the blood brain barrier 
(BBB) [5–10].
The outcomes from experiments performed on germ-free (GF) mice confirmed 
the great role of gut microbiota in the upsurge of immune system deficiencies. GF 
animals were shown to have compromised Paneth cells and low levels of natural 
killer (NK) cells, dendritic cells (DCs), and α/β + and γ/δ + T cell populations that 
play an important role in defense and pathogenesis during inflammation and infec-
tion, especially against certain types of malignancies. In addition, GF animals were 
highly susceptible to frequent infections due to a decline in angiogenin-4 (Ang4), 
a powerful antimicrobial part of the class of microbicide proteins in Paneth cells 
[5–10].
The alteration of the gut microbiota may contribute to open up the invasion of 
exogenous pathogens that may destabilize the whole intestinal mucosa. The patho-
gen systematic overgrowth will trigger a cascade of strong inflammatory responses 
making intestinal mucosa highly susceptible and motile. The chronic inflammation 
will weaken the endothelial tide junction to the point that the walls become highly 
relaxed and permeable causing the phenomenon known as “leaky gut” that allows 
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the free, uncontrolled passage of microorganism into the system via the blood-
stream and tissues where they start allocating. In fact, the presence of these typical 
gut residents could be found in eroded, inflamed, and degenerated joints and 
organs such as the lungs, heart, brain, and liver [11–13].
2.  Gut dysbiosis: a modality to understand neurodegenerative diseases: 
the disruption of blood-brain barrier (BBB) may explain the  
gut-oral-brain axis relationship
The high and uncontrolled levels of pathogenic microorganism colonizing the 
gut contribute to a condition known as dysbiosis [14]. Since few years the dysbiosis 
has been associated with a variety of degenerative patterns that tend to subvert the 
metabolic/neuro/hormonal/immune axis contributing to a variety of disorders that 
round to different body systems ranging from skeleton, cardiovascular, to neuro 
system. There are several mechanisms proposed that are able to trigger this state 
of systemic disorders; one of the possibilities is linked to bacterial metabolites and 
immune-modulating mediators that contribute to the high permeability of intesti-
nal mucosa allowing local pathogens to get through the mucosal barriers triggering 
a huge variety of immune responses. A second and though related mechanism is 
the sabotage of SCFAs’ production; the consequences of this mechanism are the 
abrupt breakdown of energy balance mechanism, a reduction of cell-bacteria 
signaling pathway, and the worsening of epithelial cell layer integrity due to the 
decreased production of tight junction proteins which allows the translocation 
of LPS into the submucosa as well. The significant presence of pro-inflammatory 
cytokines and interleukins such as TNFα, IFN-γ, IL-1β, IL-2, IL-4, IL-5, and IL-6 
is the peculiar trait of a dysbiotic gut (Figure 1) [14–16]. A third way of dysbiosis 
transmission is through the vagus nerve (VN), the main component of parasym-
pathetic nervous system (PSN) which also constitutes an effective bridge of the 
gut/CNS axis. This hypothesis, today supported by a concrete line of evidences, 
proposes the existence of a reciprocal interference way between the CNS and gut 
through the VN. In this view the VN is able to perceive microbiota movement, 
grade of activity, and therefore degradation; on the other hand, pathogens once 
out from the gut mucosa barrier are able to communicate and move to the CNS 
through the VN pathway [14–18].
These essential structural alterations are at the base of neurodegenerative 
pathologies. Though it is a unique pathological aspect, we may see the presence of 
a common configuration indeed, which is a shared neurological chronic inflam-
matory pattern. In all these cases, the chronic neuro-inflammatory condition is 
characterized by an abnormal hyperactive behavior of neural immune cells, the 
microglia, known as macrophages of the brain [18, 19]. The chronic inflammatory 
state that from the gut opens up the pathway of pathogenic microbiota invasion 
all the way through oral and brain compartment, which is the hallmark of neuro-
degenerative disorders’ dynamic pathogenesis. Patients with Parkinson’s disease 
(PD), Alzheimer’s (AD), multiple sclerosis (MS), or amyotrophic lateral sclerosis all 
present a variety of disturbances in intestinal microbial compared to healthy indi-
viduals. Neurodegenerative-affected patients’ intestinal and fecal analysis showed 
a clear clinical picture of microbiota dysbiosis. The test outcomes showed high 
level of coliform and gram-negative bacteria from Ralstonia genus concomitantly 
with low critical level of anti-inflammatory strains related to Blautia, Coprococcus, 
and Roseburia genera. Another indicator was also noted; it was the low presence of 
Prevotella generally seen as beneficial bacteria, involved in the metabolism of plant 
polysaccharides and vitamins strictly associated with the production of neuroactive 
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SCFAs, such as GABA [20–31]. The Prevotella spp. is associated with mucin-type 
O-glycan production which is extremely important in the integrity of gut epithelial 
barrier; the absence of this mucin type (mucin-2 specifically) tends to compromise 
the correct homeostatic balance of the local microbiota, increasing intestinal 
permeability, a clinical feature associated with both microbial dysbiosis and neuro-
degenerative diseases [32–34].
Disruption of the BBB is a hallmark in individuals with neurodegenerative dis-
eases that contributes to a steady and progressive death of dopaminergic neurons in 
the CNS. The BBB is a part of a systemic condition that eventually allows the inva-
sion of pathogens and immune agents from a dysbiotic gut into the CNS. However, 
damages are also due to a series of changes that weaken the integrity of microvascu-
lature and blood vessels; these modifications are mainly due to nutritional impair-
ment as a consequence of gut microbiota disturbances that cause low-level intake of 
important nutrients. Deficiencies in vitamins like C, K, D, and folates responsible 
for low hydroxylation for the formation of chondro-sulfate necessary for healthy 
microvessel endothelial walls, the augmentation of free radicals, and depletion in 
oxygen contents and nitrogen, matrix metalloproteinases (MMPs), cyclooxygenases 
(COXs), and hypoxia-inducible factor-1α (HIF-1α) are all linked with BBB disrup-
tion as neuro-inflammatory responses tend to increase and evolve [35].
Thus the scenario existing in the great majority of neurodegenerative patholo-
gies presents a combination of higher permeability of the intestinal barriers and 
the BBB, inducing a greater access between gut microbiota and the CNS compart-
ment. Experiments conducted with the use of high dose of minocycline antibiotic 
are well known to have an impact on specific gut and oral invasive bacteria; the 
post-administration results showed significant protection on LPS-induced PD 
in mice data confirmed by a significant amelioration of neuro-inflammatory 
Figure 1. 
The gut microbiota is a very dynamic ecosystem. The entire gut microbiota is composed of different sub-
environments with unique features like niches with specific microbes and tissue interactions. The large intestine 
represents the more populated area and performs the highest variety of biotransformation under the guide of 
specific gene expression in charge of enzymes necessary for highly specific biotransformation necessary of the 
SCFAs. The local flora is crucial for the local microbiome homeostasis, and the whole chain of bio-reaction 
takes place in spaces with a specific mean pH of 6.5–7. The changes in local balance homeostasis and in pH 
negatively impact on the mucosa shield that repair the outside and inside permeability gradient. Once the 
stability and the equilibrium between all the components are broken, the gut walls become fragile under the 
constant attack of local immune cells that start to deteriorate the integrity of both endothelial wall and mucosa 
shield that induce on medium long term and accumulation of pro-inflammatory endotoxins, bacteria free 
passage into the system, and low antimicrobial peptide production with a consequent high gastrointestinal 
motility.
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markers such as TNF-α expression, IL-1α expression, and microglia activation 
and a substantial amelioration of astrocyte loss with an increased number of 
surviving dopaminergic neurons compared to control LPS only-injected mice [36, 
37]. It follows that a correct use of antibiotics generally known to alter gut micro-
bial diversity may disclose a positive immune protective side effect on inflam-
matory mechanism existent in PD patients [36–38]. Several other outcomes have 
shown the beneficial effects of oral antibiotic, minocycline, and tetracycline, in 
CNS degenerative condition like the experimental autoimmune encephalopathy 
(EAE) disease and MS. It was found a significant increase of IL-10 expression 
concomitant with a favorable increase of a subset of invariant NK T cells and in 
patients with MS, and there was a substantial reduction of CNS deteriorations 
[38–42].
2.1 Crosslink between microbiota dysbiosis and osteo-decay
Aging brings generally substantial physiological alterations—hormonal, 
humoral, and physical—that involves the entire homeostatic organization of 
the human body. Of course the GI tract and its microbiota as well undergo 
through profound changes that under the variations of dietary influences bring 
to a general decline of cognitive and immune activities. With aging, the gut 
microbiota lost bacterial balanced diversity with an increase of “pathogenic 
Proteobacteria” vs. a continuing, steady, and progressive lower level of “friend 
bacteria” such as Firmicutes, Faecalibacterium prausnitzii, and Actinobacteria 
(mainly bifidobacteria) [42–45].
Another important feature of gut microbiota is the ability to modulate genes that 
can be seen either on regulation or variation; this is one of the main factors that may 
explain the influences that gut microbiota eventually exert on bone development 
and on bone-related diseases such as osteoporosis, osteopenia, or the different types 
of arthritis. The delicate homeostatic balance that regulates bone formation and 
resorption is partly played by the activity of intestinal microorganisms. This activ-
ity is basically performed through the interaction with endocrine/nervous system 
axis; thereby the hormonal activity such as serotonin, cortisol, and sex hormones 
and several growth factors affect bone mass in mice and humans. In addition, bone 
marrow stem cells, circulatory stem cells, and stem cells from bone marrow niche 
are highly sensitive to gut microenvironment condition which eventually affects the 
differentiation process toward either osteoblasts or osteoclasts. In this case it has 
been proven that the metabolic pathway compartment which involves the ribosome 
activity, glycolysis, oxidative phosphorylation, carbon metabolism, and mitochon-
dria ATP are fully responsible of regulating MSCs’ functionality, growth, prolifera-
tion, and differentiation [45, 46].
This important connection has also been confirmed by Xiao and colleagues; they 
were able to highlight through the single-cell RNA-sequencing analysis the existing 
connection between the gut microbiota, BM-MSCs, and bone metabolic functional-
ity. The presence of several factors such as the HIF-1 together with the expression 
of infection/inflammatory signaling pathways could be the scattering patterns that 
influence MSC mobility and immunomodulation. These outcomes showed how 
HIF-1 signaling is involved in BM-MSC immunomodulation. In fact, the HIF-1 
is notoriously known as a triggering factor of inflammatory transcription factor 
NFκB and an active regulator of specific cytokine and chemokine recruitment in 
inflammation and infection situations. The chronic presence of an inflammatory 
response under the triggering activity of pro-inflammatory cytokines such as the 
TNF superfamily IL-1β, IL-2, IL-4, IL-6, and IL-17 can deeply disturb the osteoclast 
and osteoblast balance, typically resulting in a net hyper-osteoclast activity and 
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thus bone loss. While there is an evident mechanical effect on the bone where these 
cytokines stimulate osteoclast differentiation with a consequent upregulation of 
RANKL expression in progenitor osteoblasts together with a higher RANKL expres-
sion, a concomitant nonmechanical effect under the downregulation of specific 
deficit due to a metabolic inability of vitamin K and vitamin D synthesis in the 
intestinal lumen should be mentioned (Figure 2) [47–54].
2.2 Probiotic efficacy in therapy and clinically use
The potential impact of the therapeutic effect of probiotic on a dysbiotic situ-
ation could not be seen without taking in consideration a change of lifestyle. Diet 
habits, stress, poor healthy conditions, and lack of exercise can significantly impact 
the gut microbiota stability [55–57]. There are many evidences that nutritional habits 
based on “Western diet” composed of huge additive and animal fats, processed glu-
cose and excessive quantities of hypercaloric nutritional facts, low contents of fresh 
food, and low level of vitamins and minerals, essential for our body, all negatively 
affect the correct balance of gut microbiota, which eventually lead to the insurgence 
of metabolic dysfunctions. It is also well known that these bad behaviors are associ-
ated with an increased risk of developing several chronic diseases that may attack 
oral microbiota and vaginal microbiota that recent study findings have indicated as 
an independent risk factor for severe neurodegenerative conditions [9, 58–60].
Figure 2. 
The gut dysbiosis is one of the main contributors in osteo-degenerative conditions. The dysbiotic 
microenvironment increase the viability of systemic pro-inflammatory cytokines and interleukins generating 
three main anti-regenerative patterns, the increase of pH acidic level, decrease of the differentiating pathway 
from MSCs and SCs toward osteoblasts, and hyper-expression of osteoclast activity. The dysbiosis generates a 
defective absorption mechanism of important nutrients for bone homeostasis like vitamins, among them K and 
D, and hormones such as serotonin, testosterone, and estrogen. The prerogative of this condition is a cascade of 
events that will involve systemically and progressively the whole vital activity of cells, tissues, and systems of the 
organism.
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By definition, probiotic refers to large and diverse types of microbes both com-
mensal that normally reside in the gut and exogenous that may migrate through 
the intestine following food or diet and supplement consumption. Probiotics might 
be composed of different microbial strains, the most common include species of 
Lactobacillus, Bifidobacterium, Streptococcus, and yeast Saccharomyces species [61].
As previously mentioned, currently there is a great interest on the use of spe-
cific probiotics as therapeutic tool to be associated as clinical approach toward 
immune system pathologies that may include autoimmune conditions that may 
attack nerves, bone, and bowel. Given the prevalence of probiotic use, the effects of 
probiotics on bone health is of significant interest.
Significant positive clinical outcomes have been obtained in numerous studies 
conducted on CNS inflammatory condition that have therapeutically used different 
types of probiotic strains. The results showed a reduction of CNS inflammatory 
level and progression; these outcomes were eventually explained by the capacity of 
certain strains (Lactobacillus species including bacteria like the Pediococcus acidilac-
tici, Bifidobacterium bifidum, Bifidobacterium animalis, Streptococcus thermophiles, 
and Bifidobacterium infantis 35,624) to modulate the expression of T-regs, B-regs, 
and IL-10 production such as [62–64].
In addition, an experiment with genetically engineered microbial strains such as 
Lactococcus lactis capable of expressing heat shock protein 65 obtained from another 
strain like the Mycobacterium leprae was seen highly efficient in reducing EAE 
symptoms and disease progression [63, 64]. The beneficial outcomes in this study 
were associated with a decrease in IL-17 pro-inflammatory interleukin with a paral-
lel growth of IL-10 evaluated in the mesenteric lymph node and spleen cell cultures. 
Furthermore, mice showed a significant higher level of endogenous CD4 + Foxp3+ 
regulatory T-regs and CD4 + LAP+ (latency-associated peptide). These results 
might be also sustained by a higher production of SCFAs that, as stated by Opazo 
and colleagues, were seen to induce either a decrease in RORγt, a biomarker of 
IL-17, or IL-23 with a higher production of IL-10 and IL-12 with a similar beneficial 
effect on both EAE and IBS [61–66].
Therefore beneficial homeostatic-metabolic effect of specific probiotic strains 
can be seen on different systems such as the cardiovascular, immune, and CNS. For 
instance, few strains conserve a natural ability of inhibiting the insurgence of 
hypercholesteremia in both mice and human. In fact the use of Lactobacillaceae 
strains such as L. acidophilus, Bifidobacterium bifidum, and L. plantarum Lp9 strain 
showed a significant role in lowering the cholesterol level under in vivo conditions 
thanks to their ability of secreting functional bile salt hydrolase (BSH), an enzyme 
crucial in the protection against the insurgence of bad cholesterol in the host. 
Genomic analysis has indicated that Lactobacillaceae especially L. plantarum contain 
the highest presence of BSH genes. Intriguingly, milk fermented by L. plantarum 
NTU 102 revealed to have a high significant efficacy on total cholesterol and LDL 
cholesterol levels though in presence of individuals undergone a cholesterol-rich 
diet [67–70].
Major depressive disorders have been seen even today as a consequence of 
decreased serotonin level; therefore, the therapeutic strategy has mainly concen-
trated on producing medication, which focused on serotonin only. The major treat-
ments are based on a class of drugs known as selective serotonin reuptake inhibitors 
(SSRIs). These SSRIs stimulate the serotonin uptake between neurons, and, though 
it has been seen some improvements, the medium long-term use has produced 
serious side effects on gut homeostatic balance with severe metabolic disturbances. 
Nowadays, as above mentioned, following the fact that current researches have 
established associations between gut microbes, digestive function, and mental 
well-being especially under the fact that serotonin is synthesized in the gut by the 
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combined activity of different microbiota strain such as Lactobacillus. The connec-
tion was firstly seen in IBS patient who also manifests clear clinical signs of depres-
sive disorders; the analysis of gut microbiota from these patients showed a very low 
level of Lactobacillus strains versus healthy subjects that might be explained by the 
increased expression of serotonin transporter (SERT) [71–74].
Overall the data on this specific topic all have evidenced the positive effects of 
probiotics in CNS health. These effects are explained by the ability of probiotics to 
directly interact with fundamental metabolic agents either within the gut or outside 
that eventually explain the Gut-CNS axis. The use of probiotics and in specific the 
Lactobacillus strains showed that mice fed with these probiotics revealed a better 
capacity of reabsorbing tryptophan amino acid the precursor or serotonin, the 
re-established normal level of those hormones strictly related to stress deviances 
and depression such as the adrenocorticotropic hormone (ACTH), corticosterone, 
adrenaline, noradrenaline and the re-increase expression of brain-derived neu-
rotrophic factor (BDNF) a marker that indicate a neuronal health and memory 
functionality [74–79].
To conclude, the higher permeability of gut or “leaky gut” intensifies the fee 
passage of endotoxins such as the LPS and other forms of molecules and pathogens 
to leak into the bloodstream and thus in the entire system. The upsurge of these 
endotoxins, pathogens, and waste molecules eventually trigger the activation of a 
cascade of immune responses through switching on the Toll-like receptor 4 (TLR4) 
that mediates the recruitment of T and B lymphocytes together with a huge number 
of pro-inflammatory cytokines, interleukins, and IgA (Figure 3) [80, 81]. The 
current position therefore considers the use of probiotics as a therapeutic tool that 
Figure 3. 
There is a strict connection between CNS and gut system. The connection takes place through the afferent and 
efferent pathways of vagus nerve that physically connects both CNS and gut. Both CNS and gut may undergo 
leaky phenomena; in both cases, the barriers of either CNS or gut become extremely permeable under the 
chronic attack of both pathogens and immune agents overexpressed on the site. This event may eventually 
explain degenerative condition of both systems including IBS, ulcerative colitis, depression, PD, AD, and MS.
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may exert beneficial effects on the CNS by improving the stability homeostasis and 
integrity of gut microbiota, decreasing systemic inflammation.
2.2.1 Probiotics in the treatment of skin and oral mucosa dysbiosis
The skin represents another system where an immense variegation of micro-
biota environment can be found. Skin diseases caused by disturbances at the 
level of local microbiota that also showed to have strict connection with gut 
dysbiosis are quite exhaustive in explaining these malevolence patterns. Psoriatic 
lesions show a very specific histopathological conformation which present highly 
infiltrated immune cells like the CD3+ T cells and dendritic cells (DCs). Psoriasis 
showed to have a genetic family trait prevalent in twins; researchers have spotted 
36 genetic loci associated with PS susceptibility 1 (PSORS1) locus on chromo-
some 6p21.3 [82, 83]. Data confirmed that most of them are directly involved in 
the overexpression of those genes that regulate part of pro-inflammatory innate 
immune responses such as the NFkB activation and interleukin (IL)-23 signaling 
pathway. Intriguingly a 2018 study performed on mice proved the use of two spe-
cific probiotic Lactobacillus strains, the L. salivarius L305 and L. rhamnosus L307, 
in alleviating the clinical symptoms of psoriasis through inhibiting the aggressive 
effect of pro-inflammatory cytokines and interleukins like TNF-α, IL-1β, IL-6, 
IL-17, and IL-22 and promoting the anti-inflammatory/modulatory activity of 
IL-4 and IL-10 [84].
In oral dysbiosis, we are facing a similar inflammatory arrangement; oral 
diseases manifest with high-grade inflammatory patterns that spread from the 
gums to the adjacent structures gradually destroying the supporting tissues of the 
teeth, both ligaments and alveolar bones, causing early loss. Similarly to psoriasis 
in periodontitis, we may encounter multifactorial condition due to a combination 
of genetic variants triggered by the initial subgingival dysbiosis and then become 
highly susceptible to wider disease progression [85].
The gram-negative bacteria such as Porphyromonas gingivalis, Tannerella 
forsythia, and Aggregatibacter actinomycetemcomitans are be able to migrate into 
the system either down to the heart, lungs, and sex apparatus or are capable 
to enter into the brain via the bloodstream or via infected periodontal sites. 
Histopathological analysis has confirmed these bacteria almost everywhere in 
atheromatous plaques, the vagina, amniotic fluid, rheumatoid arthritis bioptic 
samples, and brain plaques typical of neurodegenerative diseases AD, PD, and 
MS [86–90].
As can be seen from published studies, different strains of probiotics have been 
used for the treatment of periodontitis. Lactobacillus strains are the commonest 
used in the majority of high-grade inflammatory disease. The use of L. salivarius in 
combination with L. rhamnosus and B. subtilis together with L. reuteri and L. brevis 
probiotics has shown the most promising results. High-positive results were also 
obtained by Laleman and colleagues in using Streptococcus oralis KJ3, Streptococcus 
uberis KJ2, and Streptococcus ratti JH145 [91, 92].
Therefore an associated altered gut microbiota may lead to chronic gut dysbiosis 
and propagation of systemic injuries that involve cells, tissues, system, and the 
intrinsic dysfunction of the regenerative mechanism.
3. Conclusion
In summary, the present chapter reveals that gut microbiota and a correct 
use of probiotic may play important pleiotropic functions on several levels and 
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systems. It is now clear that there is a bidirectional interaction between micro-
biota and nervous system, microbiota and immunity, microbiota and bones, and 
eventually microbiota and mitochondria. Probiotics are getting more and more 
attention due to the increase of evidence of their benefits in many degenerative 
disorders. It shows the capacity of microbiota to restore gut and vaginal and 
oral microbiota, thus attenuating various severe inflammatory responses. All 
these findings suggest that probiotics could play a role in clinical procedure and 
therapy approaches to decrease the risk of morbidity and mortality related to CNS 
diseases, cardiovascular diseases, and bone degenerations. The shared informa-
tion presented on this chapter may also demonstrate that the traditional view on 
gut microbiota and microbiome has changed and may be eventually useful as a 
prospective medium for the delivery of superior, more precise, and personalized 
treatments in the achievement of better protective health benefits for a more and 
more aging society.
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